dipyridamole has been researched along with Genital Diseases, Female in 1 studies
Dipyridamole: A phosphodiesterase inhibitor that blocks uptake and metabolism of adenosine by erythrocytes and vascular endothelial cells. Dipyridamole also potentiates the antiaggregating action of prostacyclin. (From AMA Drug Evaluations Annual, 1994, p752)
dipyridamole : A pyrimidopyrimidine that is 2,2',2'',2'''-(pyrimido[5,4-d]pyrimidine-2,6-diyldinitrilo)tetraethanol substituted by piperidin-1-yl groups at positions 4 and 8 respectively. A vasodilator agent, it inhibits the formation of blood clots.
Genital Diseases, Female: Pathological processes involving the female reproductive tract (GENITALIA, FEMALE).
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Feri, P | 1 |
| Guaschino, S | 1 |
| Pesando, P | 1 |
| Preseglio, I | 1 |
1 other study available for dipyridamole and Genital Diseases, Female
| Article | Year |
|---|---|
[Use of dipyridamole in the prevention of postoperative thromboembolic complications in gynecologic surgery].
Topics: Dipyridamole; Female; Genital Diseases, Female; Humans; Postoperative Complications; Thromboembolism | 1982 |